Ruplizumab, CAS [[220651-94-5]]

Product Overview

• Article Name: Ruplizumab, CAS [[220651-94-5]]
• Biozol Catalog Number: MCE-HY-P99315
• Supplier Catalog Number: HY-P99315
• Alternative Catalog Number: MCE-HY-P99315-25MG,MCE-HY-P99315-10MG,MCE-HY-P99315-5MG,MCE-HY-P99315-1MG,MCE-HY-P99315-50MG
• Manufacturer: MedchemExpress
• Category: Antikörper
• Alternative Names: BG 9588, Anti-Human CD40L Recombinant Antibody, Hu5c8

Product Description

Ruplizumab (BG 9588) is a humanized anti-CD40L IgG1kappa monoclonal antibody. By binding to CD40L, Ruplizumab blocks its interaction with the CD40 receptor, inhibits T-B cell costimulatory signals, and mediates the depletion of activated T cells via the Fc segment. Ruplizumab has immunosuppressive effects. Ruplizumab can be used in the study of systemic lupus erythematosus, organ transplant rejection, and autoimmune diseases. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1][2].

Product Properties

• Molecular Weight: (145.68 kDa)
• Purity: 99.84
• CAS Number: [220651-94-5]
• Target: TNF Receptor

Application Notes

• Application Notes: MCE Product type: Inhibitory Antibodies